A Trial of BTT1023 in Patients With Primary Sclerosing Cholangitis
NCT02239211
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Primary Sclerosing Cholangitis
Interventions
DRUG:
BTT1023
Sponsor
University of Birmingham
Collaborators
[object Object]
[object Object]
[object Object]